The Technical Analyst
Select Language :
Second Sight Medical [EYESW]

Exchange: NASDAQ Capital Market

Second Sight Medical Price, Forecast, Insider, Ratings, Fundamentals & Signals

Second Sight Medical is listed at the NASDAQ Exchange

9.90% $0.220

/ 31 aug 2022 @ 00:00


Second Sight Medical: Main Fundamentals PE comparison

RATING 2022-08-30
C+
Sell
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Neutral
P/E: Sell
Price To Book: Sell
QUARTER GROWTHS
1/212/213/214/211/222/22
Revenuen/an/an/an/a
Gr.Profitn/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 | sector: PE 0
PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 | industry: PE 0
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.189 - 0.251

( +/- 14.10%)
ATR Model: 14 days

Forecast: 01:40 - $0.251

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.220 (9.90% )
Volume 0.0013 mill
Avg. Vol. 0 mill
% of Avg. Vol 0 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Second Sight Medical Products Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Second Sight Medical Products Inc

RSI

Intraday RSI14 chart for Second Sight Medical Products Inc

Last 10 Buy & Sell Signals For EYESW

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Second Sight Medical Products Inc

EYESW

Last 10 Buy Signals

Date Signal @
RPLUSDApr 25 - 17:09$22.03
QTUMUSDApr 25 - 17:09$4.04
MXUSDApr 25 - 17:09$5.05
ETHWUSDApr 25 - 17:083.90
GTCUSDApr 25 - 17:051.230
DPIUSDApr 25 - 17:03$101.41
ORAIUSDApr 25 - 16:5910.93
MNTUSDApr 25 - 16:441.136
OHMUSDApr 25 - 16:4312.22
FARMUSDApr 25 - 16:3983.57

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.